Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure
- PMID: 31507594
- PMCID: PMC6714000
- DOI: 10.3389/fimmu.2019.01966
Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure
Abstract
Recent studies demonstrate that the stable HIV-1 reservoir in resting CD4+ T cells is mostly formed from viruses circulating when combination antiretroviral therapy (ART) is initiated. Here we explore the immunological basis for these observations. Untreated HIV-1 infection is characterized by a progressive depletion of memory CD4+ T cells which mostly express CD127, the α chain of the IL-7 receptor (IL-7R). Depletion results from both direct infection and bystander loss of memory CD4+ T cells in part attributed to dysregulated IL-7/IL-7R signaling. While IL-7/IL7R signaling is not essential for the generation of effector CD4+ T cells from naïve cells, it is essential for the further transition of effectors to memory CD4+ T cells and their subsequent homeostatic maintenance. HIV-1 infection therefore limits the transition of CD4+ T cells from an effector to long-lived memory state. With the onset of ART, virus load (VL) levels rapidly decrease and the frequency of CD127+ CD4+ memory T cells increases, indicating restoration of effector to memory transition in CD4+ T cells. Collectively these data suggest that following ART initiation, HIV-1 infected effector CD4+ T cells transition to long-lived, CD127+ CD4+ T cells forming the majority of the stable HIV-1 reservoir. We propose that combining ART initiation with inhibition of IL-7/IL-7R signaling to block CD4+ T cell memory formation will limit the generation of long-lived HIV-infected CD4+ T cells and reduce the overall size of the stable HIV-1 reservoir.
Keywords: CD127; CD4+ T cell; HIV-1; IL-7; latency; memory; reservoir.
Figures


Similar articles
-
Interleukin 7 up-regulates CD95 protein on CD4+ T cells by affecting mRNA alternative splicing: priming for a synergistic effect on HIV-1 reservoir maintenance.J Biol Chem. 2015 Jan 2;290(1):35-45. doi: 10.1074/jbc.M114.598631. Epub 2014 Nov 19. J Biol Chem. 2015. PMID: 25411246 Free PMC article.
-
Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance.Blood. 2011 Sep 22;118(12):3244-53. doi: 10.1182/blood-2010-12-323600. Epub 2011 Jul 21. Blood. 2011. PMID: 21778338 Free PMC article.
-
Naive and Memory CD4⁺ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART.Viral Immunol. 2016 Apr;29(3):176-83. doi: 10.1089/vim.2015.0108. Viral Immunol. 2016. PMID: 27035638
-
Targeting the Latent Reservoir for HIV-1.Immunity. 2018 May 15;48(5):872-895. doi: 10.1016/j.immuni.2018.04.030. Immunity. 2018. PMID: 29768175 Free PMC article. Review.
-
Peering into the HIV reservoir.Rev Med Virol. 2018 Jul;28(4):e1981. doi: 10.1002/rmv.1981. Epub 2018 May 9. Rev Med Virol. 2018. PMID: 29744964 Free PMC article. Review.
Cited by
-
Curing HIV: Seeking to Target and Clear Persistent Infection.Cell. 2020 Apr 2;181(1):189-206. doi: 10.1016/j.cell.2020.03.005. Epub 2020 Mar 26. Cell. 2020. PMID: 32220311 Free PMC article. Review.
-
A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells.Cell Chem Biol. 2023 Dec 21;30(12):1617-1633.e9. doi: 10.1016/j.chembiol.2023.11.009. Cell Chem Biol. 2023. PMID: 38134881 Free PMC article.
-
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention.Viruses. 2023 Jul 31;15(8):1677. doi: 10.3390/v15081677. Viruses. 2023. PMID: 37632019 Free PMC article. Review.
-
Enhancer of zeste homolog 1/2 dual inhibitor valemetostat outperforms enhancer of zeste homolog 2-selective inhibitors in reactivating latent HIV-1 reservoirs ex vivo.Front Microbiol. 2025 Apr 10;16:1581330. doi: 10.3389/fmicb.2025.1581330. eCollection 2025. Front Microbiol. 2025. PMID: 40276229 Free PMC article.
-
Dominant CD4+ T cell receptors remain stable throughout antiretroviral therapy-mediated immune restoration in people with HIV.Cell Rep Med. 2023 Nov 21;4(11):101268. doi: 10.1016/j.xcrm.2023.101268. Epub 2023 Nov 9. Cell Rep Med. 2023. PMID: 37949070 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials